Legato Capital Management’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
VPM
3C
VCM
6CM
Legato Capital Management's ASTH Position: Q1 2026 in Review
Legato Capital Management sold out of Astrana Health (ASTH) in Q1 2026, closing a stake of 27,739 shares — an estimated $688K sold.
Legato Capital Management first reported a position in ASTH in Q2 2021 and held it in 3 quarters. The position peaked at $688K in Q4 2025. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.
- Legato Capital Management reported no remaining Astrana Health position as of Q1 2026 after selling out during the quarter.
- Legato Capital Management sold 27,739 Astrana Health shares in Q1 2026, an estimated $688K.
- Legato Capital Management first reported a position in Astrana Health in Q2 2021 and held it in 3 quarters.
- Legato Capital Management's Astrana Health position peaked at $688K in Q4 2025.
- 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.
Based on Legato Capital Management's 13F filing for Q1 2026, filed 14 May 2026.